Distribution characteristics of immune infiltration and lymphovascular invasion in patients with breast cancer skin recurrence.
Zhou D, Li M, Wu W, Wu Y, Nong Q, Wang S, Hong R.
Cancer Immunol Immunother. 2024 Sep 5;73(11):223. doi: 10.1007/s00262-024-03783-6.
Occult metastasis.
Hawes D, Neville AM, Cote RJ.
Biomed Pharmacother. 2001 May;55(4):229-42. doi: 10.1016/s0753-3322(01)00052-x.
Downregulated circPOKE promotes breast cancer metastasis through activation of the USP10-Snail axis.
Luo Y, Zhu Q, Xiang S, Wang Q, Li J, Chen X, Yan W, Feng J, Zu X.
Oncogene. 2023 Oct;42(44):3236-3251. doi: 10.1038/s41388-023-02823-2. Epub 2023 Sep 16.
Erysipelas carcinomatosum.
Vandersee S.
Dtsch Arztebl Int. 2019 Jan 7;116(1-2):22. doi: 10.3238/arztebl.2019.0022b.
Secondary mucinous carcinoma of the skin.
Frances L, Cuesta L, Leiva-Salinas M, Bañuls J.
Dermatol Online J. 2014 Apr 16;20(4):22361.
Breast Metastasis as a Presentation of Malignant Melanoma.
Asaad A, Abdalla AS, Idaewor P, Jayasooryia B, Yates V, Eldruki S, English J.
Chirurgia (Bucur). 2018 Sept-Oct;113(5):712-718. doi: 10.21614/chirurgia.113.5.712.
Primary melanoma of skin of the breast region.
Lee YT, Sparks FC, Morton DL.
Ann Surg. 1977 Jan;185(1):17-22. doi: 10.1097/00000658-197701000-00003.
Metastatic nonhematopoietic neoplasms to the breast: a study of 238 cases.
Zhou P, Chang N, Abraham SC, Albarracin CT, Huo L, Chen H, Ding Q, Resetkova E, Middleton LP, Sahin AA, Bu H, Wu Y.
Hum Pathol. 2022 Jul;125:59-67. doi: 10.1016/j.humpath.2022.04.009. Epub 2022 Apr 18.
Breast metastases of eccrine porocarcinoma.
Pinto JF, Vasconcelos MA, Marques RC, Chumbo M.
BMJ Case Rep. 2022 Mar 7;15(3):e247900. doi: 10.1136/bcr-2021-247900.
Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature.
Kurul S, Taş F, Büyükbabani N, Mudun A, Baykal C, Camlica H.
Jpn J Clin Oncol. 2005 Apr;35(4):202-6. doi: 10.1093/jjco/hyi068.
